HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kalivianakis, M. Articles by Verkade, H. J Search for Related Content PubMed PubMed Citation Articles by Kalivianakis, M. Articles by Verkade, H. J Agricola Articles by Kalivianakis, M. Articles by Verkade, H. J

Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids^1,2,3

Background: Pancreatic enzyme replacement therapy frequently fails to correct intestinal fat malabsorption completely in cystic fibrosis (CF) patients. The reason for this failure is unknown.

Objective: We investigated whether fat malabsorption in CF patients treated with pancreatic enzymes is caused by insufficient lipolysis of triacylglycerols or by defective intestinal uptake of long-chain fatty acids.

Design: Lipolysis was determined on the basis of breath ¹³CO₂ recovery in 10 CF patients receiving pancreatic enzyme replacement therapy after they ingested 1,3-distearoyl,2[1-¹³C]octanoyl glycerol ([¹³C]MTG). Intestinal uptake of long-chain fatty acids was determined by analyzing plasma [¹³C]linoleic acid ([¹³C]LA) concentrations after patients ingested [¹³C]LA. For 3 d, dietary intakes were recorded and feces were collected.

Results: Fecal fat excretion ranged from 5.1 to 27.8 g/d ( ± SD: 11.1 ± 7.0 g/d) and fat absorption ranged from 79% to 93% (89 ± 5%). There was no relation between breath ¹³CO₂ recovery and dietary fat absorption (r = 0.04) after ingestion of [¹³C]MTG. In contrast, there was a strong relation between 8-h plasma [¹³C]LA concentrations and dietary fat absorption (r = 0.88, P < 0.001).

Conclusion: Our results suggest that continuing fat malabsorption in CF patients receiving enzyme replacement therapy is not likely due to insufficient lipolytic enzyme activity, but rather to incomplete intraluminal solubilization of long-chain fatty acids, reduced mucosal uptake of long-chain fatty acids, or both.

Key Words: Breath test • mixed triacylglycerol • [¹³C]linoleic acid • fat malabsorption • fat balance • lipolysis • stable isotopes • cystic fibrosis • recommended dietary allowance • children • long-chain fatty acids

This article has been cited by other articles:

				R. C. De Lisle Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G104 - G111. [Abstract] [Full Text] [PDF]

				J. Trabulsi, J. I Schall, R. F Ittenbach, I. E Olsen, M. Yudkoff, Y. Daikhin, B. S Zemel, and V. A Stallings Energy balance and the accuracy of reported energy intake in preadolescent children with cystic fibrosis. Am. J. Clinical Nutrition, September 1, 2006; 84(3): 523 - 530. [Abstract] [Full Text] [PDF]

				M. J. C. Bijvelds, I. Bronsveld, R. Havinga, M. Sinaasappel, H. R. de Jonge, and H. J. Verkade Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G646 - G653. [Abstract] [Full Text] [PDF]

				V. G. Geukers, J. H Oudshoorn, J. A. Taminiau, C. K van der Ent, P. Schilte, A. F. Ruiter, M. T Ackermans, E. Endert, C. F Jonkers-Schuitema, H. S. Heymans, et al. Short-term protein intake and stimulation of protein synthesis in stunted children with cystic fibrosis Am. J. Clinical Nutrition, March 1, 2005; 81(3): 605 - 610. [Abstract] [Full Text] [PDF]

				A. H Chen, S. M Innis, A G. F Davidson, and S J. James Phosphatidylcholine and lysophosphatidylcholine excretion is increased in children with cystic fibrosis and is associated with plasma homocysteine, S-adenosylhomocysteine, and S-adenosylmethionine Am. J. Clinical Nutrition, March 1, 2005; 81(3): 686 - 691. [Abstract] [Full Text] [PDF]

				S. A. Schuette, M. Janghorbani, M. B. Cohen, S. Krug, T. Schindler, D. A. Wagner, and E. P. DiMagno Effect of Triglyceride Structure on Fecal Excretion of 13C-Labeled Triglycerides J. Am. Coll. Nutr., December 1, 2003; 22(6): 511 - 518. [Abstract] [Full Text] [PDF]

				V. Figueroa, C. Milla, E. J Parks, S. J. Schwarzenberg, and A. Moran Abnormal lipid concentrations in cystic fibrosis Am. J. Clinical Nutrition, June 1, 2002; 75(6): 1005 - 1011. [Abstract] [Full Text] [PDF]

				D. M. Minich, R. Havinga, F. Stellaard, R. J. Vonk, F. Kuipers, and H. J. Verkade Intestinal absorption and postabsorptive metabolism of linoleic acid in rats with short-term bile duct ligation Am J Physiol Gastrointest Liver Physiol, December 1, 2000; 279(6): G1242 - G1248. [Abstract] [Full Text] [PDF]

				M. Kalivianakis, D. M Minich, R. Havinga, F. Kuipers, F. Stellaard, R. J Vonk, and H. J Verkade Detection of impaired intestinal absorption of long-chain fatty acids: validation studies of a novel test in a rat model of fat malabsorption Am. J. Clinical Nutrition, July 1, 2000; 72(1): 174 - 180. [Abstract] [Full Text] [PDF]

				H. J Verkade Reply to J Murphy et al Am. J. Clinical Nutrition, November 1, 1999; 70(5): 945 - 946. [Full Text]

				J. Murphy, K. Laiho, and S. Wootton Fat malabsorption in cystic fibrosis patients Am. J. Clinical Nutrition, November 1, 1999; 70(5): 943 - 944. [Full Text]